Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L3XV
|
|||
Former ID |
DIB016880
|
|||
Drug Name |
SMART anti-E/P selectin
|
|||
Synonyms |
HuEP5C7; Bispecific anti-E/P selectin, PDL; SMART anti-E/P selectin, PDL; SMART anti-E/P selectin, Protein Design Labs; Anti-E/P selectin (humanized), PDL
Click to Show/Hide
|
|||
Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Discontinued in Phase 1 | [1] | |
Company |
PDL BioPharma Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | E-selectin (SELE) | Target Info | Modulator | [2] |
P-selectin (SELP) | Target Info | Modulator | [2] | |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
Malaria | ||||
Staphylococcus aureus infection | ||||
TNF signaling pathway | ||||
African trypanosomiasis | ||||
NetPath Pathway | IL5 Signaling Pathway | |||
IL4 Signaling Pathway | ||||
TNFalpha Signaling Pathway | ||||
ID Signaling Pathway | ||||
Pathway Interaction Database | IL4-mediated signaling events | |||
amb2 Integrin signaling | ||||
Thromboxane A2 receptor signaling | ||||
Glucocorticoid receptor regulatory network | ||||
ATF-2 transcription factor network | ||||
Reactome | Platelet degranulation | |||
Cell surface interactions at the vascular wall | ||||
WikiPathways | Human Complement System | |||
Spinal Cord Injury | ||||
Cell surface interactions at the vascular wall | ||||
TNF alpha Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008129) | |||
REF 2 | HuEP5C7 as a humanized monoclonal anti-E/P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circ Res. 2002 Nov 15;91(10):907-14. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.